Cleave Biosciences (later renamed Cleave Therapeutics) is a biopharmaceutical company headquartered in Burlingame, California, focused on developing small molecule therapies targeting protein homeostasis and cellular stress pathways in cancer. The company's lead program centers on VCP/p97 inhibition as a novel mechanism for treating difficult-to-treat cancers.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account